Faron Pharmaceuticals: Interview with CEO Markku Jalkanen (video)
Research Interview
2022-08-29
08:25
Redeye has interviewed Markku Jalkanen, CEO of Faron Pharmaceuticals. We discuss the clinical progress with lead candidate Bexmarilimab and the company's recent H1 report.
KS
Kevin Sule
Disclosures and disclaimers